June 21st 2024
An analysis from Harvard shows there is no significantly increased newborn risk when continuing metformin to treat type 2 diabetes in pregnant women.
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant ...
November 20, 2024
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Postpartum etonogestrel-releasing implants and depression
June 24th 2020Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.
Read More
Juneteenth: Celebrating Black women in obstetrics and gynecology
June 19th 2020June 19, 1865, also known as Juneteenth, celebrates the end of slavery in the United States. On this day nearly 160 years ago, Union troops arrived in Galveston, TX to announce the end of the Civil War and the emancipation of slavery in the United States.
Read More
Port-site local anesthetic injection for laparoendoscopic surgery
June 18th 2020A South Korean prospective study has concluded that an injection of port-site bupivacaine hydrochloride following gynecologic laparoendoscopic single-site surgery (LSSS) does not provide any additive effect in alleviating postoperative umbilical pain.
Read More
Pregnancy in deaf and hard of hearing women
June 16th 2020Women who are deaf or hard of hearing have a higher risk of complications in pregnancy, according to a study funded by the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Read More
Paucity of evidence limits known impact of CSPs
June 12th 2020As we are now incorporating the new post-COVID-19 “normal” into our routines, our editor-in-chief, Dr. Catherine Spong, reflects on parallels with changes that went into play with the identification and management of patients with HIV.
Read More
Cesarean scar pregnancy (CSP) is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. Incidence and recognition of this condition appear to have increased over the past two decades, perhaps due to high worldwide cesarean delivery rates. The clinical presentation is variable, and many women are asymptomatic at presentation. CSP can be difficult to diagnose in a timely fashion. Ultrasound is the primary imaging modality for CSP diagnosis. Expectantly managed CSP is associated with high rates of severe maternal morbidity such as hemorrhage, placenta accreta spectrum (PAS), and uterine rupture. Given these substantial risks, pregnancy termination is recommended after CSP diagnosis. Several surgical and medical treatments have been described for this disorder, but at this time, optimal management remains uncertain.
Read More
The Society for Maternal-Fetal Medicine consult series #49 on cesarean scar pregnancy
Cesarean scar pregnancy (CSP) is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. Incidence and recognition of this condition appear to have increased over the past two decades, perhaps due to high worldwide cesarean delivery rates. The clinical presentation is variable, and many women are asymptomatic at presentation. CSP can be difficult to diagnose in a timely fashion. Ultrasound is the primary imaging modality for CSP diagnosis. Expectantly managed CSP is associated with high rates of severe maternal morbidity such as hemorrhage, placenta accreta spectrum (PAS), and uterine rupture. Given these substantial risks, pregnancy termination is recommended after CSP diagnosis. Several surgical and medical treatments have been described for this disorder, but at this time, optimal management remains uncertain.
Read More
Does adding a Foley to misoprostol lower risk of cesarean in obese women?
May 19th 2020Risk of labor induction and cesarean delivery is increased in nulliparas who are obese, and use of misoprostol or insertion of a Foley balloon often fails in these patients, for reasons that aren’t fully understood.
Read More
Embracing the Unknown: What It’s Like Prepping as a First-Time Mom During the COVID-19 Pandemic
May 18th 2020Jamie Barretto is a 34-year-old first-time mother who lives on Long Island. She wrote this first-person perspective on how life has changed in her world since she found out she was expecting in October.
Read More